Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 2 Clinical characteristics of patients with esophageal varices at UOGCSH GI follow-up clinic from May to September 2022 (n = 150)

From: Dose optimization of non-selective beta blockers among esophageal varices patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a hospital-based cross-sectional study

Variable

 

Frequency

Percent

Sitting SBP(mean ± SD) (101.9 ± 9.96)

less than 90

1

0.7

90–139

148

98.7

Greater than 140

1

0.7

Sitting DBP(mean ± SD) (65.37 ± 7.19)

Less than 60

1

0.7

60–89

148

98.7

Greater than 90

1

0.7

Standing SBP(mean ± SD) (99.73 ± 11.29)

Less than 90

14

9.3

90–139

135

90.0

Greater than 140

1

0.7

Standing DBP(mean ± SD) (63.93 ± 7.41)

Less than 60

9

6.0

60–89

140

93.3

Greater than 90

1

0.7

BMI(mean + SD) (19 + 1.61)

Underweight

51

34

Normal

96

64

Overweight

3

2

MUAC(mean + SD) (21.76 + 2.30)

Wasting

65

43.3

Normal

85

56.7

Grading of varices

F1

35

23.3

F2

53

35.3

F3

62

41.3

Causes of varices

CLD

68

45.3

HSS

80

53.3

PVT

2

1.3

Cirrhosis

Yes

86

57.3

No

64

42.7

Child–Pugh class

A

22

25.58

B

37

43.02

C

27

31.39

Causes of cirrhosis

HBV

22

25.58

HCV

16

18.60

HSS

18

20.93

ALD

20

23.25

UNKNOWN

7

8.14

OTHERS

3

3.49

Identified CLD complications

Ascites

126

84.0

HE

8

5.3

PVT

15

10.0

HRS

9

6.0

Previous admission

Yes

60

40.0

No

90

60.0

Number of admission( previous 01 year) (mean + SD) (1.22 + 0.64)

one admission

53

35.3

 > 1 admission

7

4.7

Duration of B-blocker use in months( mean + SD) (27.82 + 20.44)

less than24

56

37.3

greater than 24

94

62.7

Identified comorbidities

CKD

7

4.7

Hypertension

2

1.3

DM

2

1.3

Asthma

1

0.7

Malignancy

1

0.7